|
28 Companies |
|
20 Products |
|
20 Products |
|
0 Mechanisms of Action |
|
56 Trials |
|
636 News |
|
| 1234567891011» |
- | Enrollment change: Satisfaction Rates Among Parents of Children With Autism in the ED (clinicaltrials.gov) - Dec 9, 2024
P=N/A, N=63, Terminated, Sponsor: Seton Healthcare Family
N=116 --> 63
- | NN1213 / Novo Nordisk
Enrollment closed, Trial completion date, Trial primary completion date: Understanding the Effects of Intervention on the Brain in Autism (clinicaltrials.gov) - Apr 19, 2023
P=N/A, N=400, Active, not recruiting, Sponsor: Marquette University
N=116 --> 63 Recruiting --> Active, not recruiting | Trial completion date: Dec 2025 --> May 2023 | Trial primary completion date: Dec 2025 --> May 2023
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: RCT of TeachTown in Autism Support Classrooms: Innovation and Exnovation (clinicaltrials.gov) - Apr 18, 2019
P=N/A, N=212, Completed, Sponsor: University of Pennsylvania
Recruiting --> Active, not recruiting | Trial completion date: Dec 2025 --> May 2023 | Trial primary completion date: Dec 2025 --> May 2023 Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Jun 2018
- ||||| Melatobel (melatonin) / Nobelpharma
Trial completion, Trial completion date, Trial primary completion date: Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders (clinicaltrials.gov) - Apr 16, 2019
P2/3, N=196, Completed, Sponsor: Nobelpharma
Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Jun 2018 Not yet recruiting --> Completed | Trial completion date: Jul 2017 --> Sep 2018 | Trial primary completion date: Jul 2017 --> Sep 2018
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: SUFFP: Syracuse University Fit Families Program: Autism (clinicaltrials.gov) - Apr 4, 2019
P=N/A, N=36, Completed, Sponsor: Syracuse University
Not yet recruiting --> Completed | Trial completion date: Jul 2017 --> Sep 2018 | Trial primary completion date: Jul 2017 --> Sep 2018 Recruiting --> Completed | N=90 --> 36
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date: Replication of the The Multi-Media Social Skills Project for Adolescents With Autism Spectrum Disorders (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=155, Completed, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Completed | N=90 --> 36 Recruiting --> Completed | N=300 --> 155 | Trial completion date: Aug 2018 --> Apr 2018
- | Trial completion, Trial completion date, Trial primary completion date: Effectiveness of the Care Coordination, Assessment, and Responsive Engagement Program for Transition-aged Adolescents (t-CARE) With ASD (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=52, Completed, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Completed | N=300 --> 155 | Trial completion date: Aug 2018 --> Apr 2018 Recruiting --> Completed | Trial completion date: Feb 2019 --> Apr 2018 | Trial primary completion date: Feb 2019 --> Apr 2018
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: The Multi-Media Social Skills Project for Adults (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=199, Completed, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Completed | Trial completion date: Feb 2019 --> Apr 2018 | Trial primary completion date: Feb 2019 --> Apr 2018 Recruiting --> Completed | N=360 --> 199 | Trial completion date: Jan 2019 --> Apr 2018 | Trial primary completion date: Oct 2018 --> Apr 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: rTMS for Executive Function Deficits in Autism Spectrum Disorder (clinicaltrials.gov) - Mar 6, 2019
P=N/A, N=40, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed | N=360 --> 199 | Trial completion date: Jan 2019 --> Apr 2018 | Trial primary completion date: Oct 2018 --> Apr 2018 Active, not recruiting --> Completed | Trial completion date: Oct 2018 --> May 2018 | Trial primary completion date: Jun 2017 --> May 2018
- | NN1213 / Novo Nordisk
Trial completion: Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters (clinicaltrials.gov) - Feb 18, 2019
P=N/A, N=85, Completed, Sponsor: IRCCS Fondazione Stella Maris
Active, not recruiting --> Completed | Trial completion date: Oct 2018 --> May 2018 | Trial primary completion date: Jun 2017 --> May 2018 Recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: Cannabinoids for Behavioral Problems in Children With ASD (clinicaltrials.gov) - Dec 27, 2018
P2, N=150, Completed, Sponsor: Shaare Zedek Medical Center
Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jul 2019 --> Dec 2018 | Trial primary completion date: Jan 2019 --> Oct 2018
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date: Sleep, Autonomic Nervous System and Cardiorespiratory Capacity in Autism Spectrum Disorders Children (APAUTRES) (clinicaltrials.gov) - Oct 30, 2018
P=N/A, N=78, Completed, Sponsor: University Hospital, Grenoble
Active, not recruiting --> Completed | Trial completion date: Jul 2019 --> Dec 2018 | Trial primary completion date: Jan 2019 --> Oct 2018 Active, not recruiting --> Completed | N=140 --> 78 | Trial completion date: Mar 2019 --> Jun 2017
- | NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Stem Cell Therapy in Autism Spectrum Disorders (clinicaltrials.gov) - Oct 25, 2018
P1, N=0, Withdrawn, Sponsor: Neurogen Brain and Spine Institute
Active, not recruiting --> Completed | N=140 --> 78 | Trial completion date: Mar 2019 --> Jun 2017 N=162 --> 0 | Completed --> Withdrawn
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial primary completion date: Addressing Systemic Health Disparities in Early Identification and Treatment of Autism Spectrum Disorder (ASD): ABCD Project (clinicaltrials.gov) - Oct 22, 2018
P=N/A, N=31, Completed, Sponsor: University of Massachusetts, Boston
N=162 --> 0 | Completed --> Withdrawn Enrolling by invitation --> Completed | N=118 --> 31 | Trial primary completion date: Sep 2019 --> Apr 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder (clinicaltrials.gov) - Oct 12, 2018
P1, N=21, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Enrolling by invitation --> Completed | N=118 --> 31 | Trial primary completion date: Sep 2019 --> Apr 2018 Recruiting --> Completed | Trial completion date: Dec 2018 --> May 2018
- | NN1213 / Novo Nordisk
Biomarker, Trial completion, Trial completion date, Trial primary completion date: Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD) (clinicaltrials.gov) - Oct 10, 2018
P=N/A, N=110, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Completed | Trial completion date: Dec 2018 --> May 2018 Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Sep 2018 | Trial primary completion date: Jan 2018 --> Aug 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: BCIAUT: BCI (Brain Computer Interface) Intervention in Autism (clinicaltrials.gov) - Sep 19, 2018
P=N/A, N=17, Completed, Sponsor: University of Coimbra
Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Sep 2018 | Trial primary completion date: Jan 2018 --> Aug 2018 Enrolling by invitation --> Completed | Trial completion date: Dec 2018 --> Sep 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: NF-ASD: Rt-fMRI NF Intervention Study in ASD (clinicaltrials.gov) - Sep 19, 2018
P=N/A, N=15, Completed, Sponsor: University of Coimbra
Enrolling by invitation --> Completed | Trial completion date: Dec 2018 --> Sep 2018 Enrolling by invitation --> Completed | Trial completion date: Dec 2018 --> Sep 2018 | Trial primary completion date: Dec 2017 --> Sep 2017
- | mirtazapine / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders (clinicaltrials.gov) - Sep 11, 2018
P3, N=30, Completed, Sponsor: Massachusetts General Hospital
Enrolling by invitation --> Completed | Trial completion date: Dec 2018 --> Sep 2018 | Trial primary completion date: Dec 2017 --> Sep 2017 Recruiting --> Completed | Trial completion date: Jul 2018 --> Oct 2017 | Trial primary completion date: Jul 2018 --> Oct 2017
- | NN1213 / Novo Nordisk
Trial primary completion date: SUFFP: Syracuse University Fit Families Program: Autism (clinicaltrials.gov) - Sep 11, 2018
P=N/A, N=90, Recruiting, Sponsor: Syracuse University
Recruiting --> Completed | Trial completion date: Jul 2018 --> Oct 2017 | Trial primary completion date: Jul 2018 --> Oct 2017 Trial primary completion date: May 2018 --> Nov 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Schema, Emotion and Behavior-Based Therapy for School Children (clinicaltrials.gov) - Sep 7, 2018
P=N/A, N=44, Completed, Sponsor: University of California, Los Angeles
Trial primary completion date: May 2018 --> Nov 2018 Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Jun 2016
- | Trial completion: SEBASTIEN: Schema, Emotion, and Behavior Therapy for Children (clinicaltrials.gov) - Sep 7, 2018
P=N/A, N=70, Completed, Sponsor: University of California, Los Angeles
Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Jun 2016 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: A2MT: a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) (clinicaltrials.gov) - Sep 5, 2018
P=N/A, N=40, Completed, Sponsor: Northumbria University
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2018 --> Sep 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Improving Autism Screening With Brain-Related miRNA (clinicaltrials.gov) - Aug 22, 2018
P=N/A, N=304, Completed, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Completed | Trial completion date: Dec 2018 --> Sep 2018 Recruiting --> Completed | Trial completion date: Dec 2019 --> Aug 2018 | Trial primary completion date: Dec 2018 --> Aug 2018
- | Trial completion date, Trial termination: Satisfaction Rates Among Parents of Children With Autism in the ED (clinicaltrials.gov) - Aug 2, 2018
P=N/A, N=116, Terminated, Sponsor: Seton Healthcare Family
Recruiting --> Completed | Trial completion date: Dec 2019 --> Aug 2018 | Trial primary completion date: Dec 2018 --> Aug 2018 Recruiting --> Terminated | Trial completion date: May 2017 --> Jan 2017; Seton IRB administratively closed this study on January 6, 2017
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Comparison of Effectiveness of Home Based Sensory Interventions Along With Standard Therapy Versus Standard Therapy Alone in Autistic Children With Sensory Processing Abnormalities (clinicaltrials.gov) - Aug 1, 2018
P=N/A, N=40, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting --> Terminated | Trial completion date: May 2017 --> Jan 2017; Seton IRB administratively closed this study on January 6, 2017 Recruiting --> Completed | N=30 --> 40 | Trial completion date: Jun 2016 --> Dec 2017 | Trial primary completion date: Jun 2016 --> Jun 2017
- | NN1213 / Novo Nordisk
Trial completion, Phase classification, Trial primary completion date: Improving Social Cognition for Adults With ASD by the Serious Game JeStiMulE Versus Controls (clinicaltrials.gov) - Jul 31, 2018
P=N/A, N=30, Completed, Sponsor: Fondation Lenval
Recruiting --> Completed | N=30 --> 40 | Trial completion date: Jun 2016 --> Dec 2017 | Trial primary completion date: Jun 2016 --> Jun 2017 Recruiting --> Completed | Phase classification: P2/3 --> PN/A | Trial primary completion date: Sep 2017 --> Sep 2016
- | Trial completion: Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project (clinicaltrials.gov) - Jul 31, 2018
P=N/A, N=35, Completed, Sponsor: Fondation Lenval
Recruiting --> Completed | Phase classification: P2/3 --> PN/A | Trial primary completion date: Sep 2017 --> Sep 2016 Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Targeting Sleep in Kids With Autism Spectrum Disorder (clinicaltrials.gov) - Jul 20, 2018
P=N/A, N=30, Completed, Sponsor: University of Missouri-Columbia
Recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion date: rTMS for Executive Function Deficits in Autism Spectrum Disorder (clinicaltrials.gov) - Jul 18, 2018
P=N/A, N=40, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Trial completion date: May 2018 --> Oct 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Comprehensive Communication Intervention for Minimally Verbal Children With Autism (clinicaltrials.gov) - Jul 12, 2018
P=N/A, N=74, Completed, Sponsor: Vanderbilt University
Trial completion date: May 2018 --> Oct 2018 Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Mar 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: AIM HI: Effectiveness and Implementation of a Mental Health Intervention for ASD (clinicaltrials.gov) - Jul 9, 2018
P=N/A, N=609, Completed, Sponsor: University of California, San Diego
Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Mar 2018 Enrolling by invitation --> Completed | Trial completion date: Feb 2017 --> Feb 2018 | Trial primary completion date: Feb 2017 --> Feb 2018
- | Trial completion date, Trial suspension, Trial primary completion date: Parenting a Child With Autism Spectrum Disorder and Marital Status (clinicaltrials.gov) - Jul 2, 2018
P=N/A, N=200, Suspended, Sponsor: Sheba Medical Center
Enrolling by invitation --> Completed | Trial completion date: Feb 2017 --> Feb 2018 | Trial primary completion date: Feb 2017 --> Feb 2018 Trial completion date: Jan 2018 --> Jan 2020 | Recruiting --> Suspended | Trial primary completion date: Jan 2018 --> Jan 2020
- | NN1213 / Novo Nordisk
Trial completion date: BCIAUT: BCI (Brain Computer Interface) Intervention in Autism (clinicaltrials.gov) - Jun 6, 2018
P=N/A, N=16, Enrolling by invitation, Sponsor: University of Coimbra
Trial completion date: Jan 2018 --> Jan 2020 | Recruiting --> Suspended | Trial primary completion date: Jan 2018 --> Jan 2020 Trial completion date: Dec 2017 --> Dec 2018
- | NN1213 / Novo Nordisk
Trial completion date: NF-ASD: Rt-fMRI NF Intervention Study in ASD (clinicaltrials.gov) - Jun 6, 2018
P=N/A, N=16, Enrolling by invitation, Sponsor: University of Coimbra
Trial completion date: Dec 2017 --> Dec 2018 Trial completion date: Dec 2017 --> Dec 2018
- | Enrollment change: Modulation of Reinforcement Learning (clinicaltrials.gov) - May 1, 2018
P=N/A, N=60, Completed, Sponsor: RWTH Aachen University
Trial completion date: Dec 2017 --> Dec 2018 N=46 --> 60
- | Enrollment closed: Cannabinoids for Behavioral Problems in Children With ASD (clinicaltrials.gov) - Apr 26, 2018
P2, N=150, Active, not recruiting, Sponsor: Shaare Zedek Medical Center
N=46 --> 60 Recruiting --> Active, not recruiting
- Trial termination: Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children. (clinicaltrials.gov) - Apr 18, 2018
P2, N=20, Terminated, Sponsor: Brainsway
Recruiting --> Active, not recruiting Not yet recruiting --> Terminated; Sponsor decision to stop the study
- | Trial completion, Trial completion date, Trial primary completion date: ASD-CXCR4: Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=400, Completed, Sponsor: Hadassah Medical Organization
Not yet recruiting --> Terminated; Sponsor decision to stop the study Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2018 | Trial primary completion date: Sep 2017 --> Apr 2018
- ||| Trial completion: An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD) (clinicaltrials.gov) - Apr 11, 2018
P=N/A, N=56, Completed, Sponsor: Enzymotec
Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2018 | Trial primary completion date: Sep 2017 --> Apr 2018 Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Community Based Intervention for Children With ADHD and ASD (clinicaltrials.gov) - Apr 4, 2018
P=N/A, N=148, Completed, Sponsor: Lauren Kenworthy
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=110 --> 148
- | trichuris suis ova (CNDO-201) / Fortress
Trial completion: TSO: Trichuris Suis Ova in Autism Spectrum Disorders (clinicaltrials.gov) - Apr 3, 2018
P1, N=10, Completed, Sponsor: Montefiore Medical Center
Active, not recruiting --> Completed | N=110 --> 148 Active, not recruiting --> Completed
- ||||||| Circadin (melatonin prolonged release) / Lundbeck, Neurim, Flynn Pharma, Grupo Insud, Biocodex, Kuhnil Pharma
Trial completion, Trial completion date, Trial primary completion date: Efficacy and Safety of Circadin (clinicaltrials.gov) - Mar 30, 2018
P3, N=125, Completed, Sponsor: Neurim Pharmaceuticals Ltd.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Mar 2018 | Trial primary completion date: Aug 2017 --> Mar 2018
- Trial primary completion date: A2MT: a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) (clinicaltrials.gov) - Mar 29, 2018
P=N/A, N=40, Recruiting, Sponsor: Northumbria University
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Mar 2018 | Trial primary completion date: Aug 2017 --> Mar 2018 Trial primary completion date: Jan 2018 --> Jul 2018
- | Trial completion, Trial completion date, Trial primary completion date: MGHTCT: Feasibility and Effectiveness of Computerized Cognitive Training in Adolescents With Autism Spectrum Disorder (clinicaltrials.gov) - Mar 27, 2018
P=N/A, N=29, Completed, Sponsor: Massachusetts General Hospital
Trial primary completion date: Jan 2018 --> Jul 2018 Enrolling by invitation --> Completed | Trial completion date: Dec 2018 --> Aug 2017 | Trial primary completion date: Dec 2018 --> Aug 2017
- | Trial completion, Enrollment change, Trial completion date: Treatment of Feeding Problems in Children With Autism (clinicaltrials.gov) - Mar 26, 2018
P=N/A, N=54, Completed, Sponsor: University of Florida
Enrolling by invitation --> Completed | Trial completion date: Dec 2018 --> Aug 2017 | Trial primary completion date: Dec 2018 --> Aug 2017 Active, not recruiting --> Completed | N=78 --> 54 | Trial completion date: May 2018 --> Jun 2017
- | Trial completion date: rTMS for Executive Function Deficits in Autism Spectrum Disorder (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=40, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Active, not recruiting --> Completed | N=78 --> 54 | Trial completion date: May 2018 --> Jun 2017 Trial completion date: Nov 2017 --> May 2018
- | Nypta (tideglusib) / ASD Therap
Trial completion: Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders (clinicaltrials.gov) - Mar 14, 2018
P2, N=83, Completed, Sponsor: Evdokia Anagnostou
Trial completion date: Nov 2017 --> May 2018 Active, not recruiting --> Completed
- ||| Trial completion, Trial completion date, Trial primary completion date: e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder (clinicaltrials.gov) - Mar 2, 2018
P=N/A, N=97, Completed, Sponsor: 3-C Institute for Social Development
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Oct 2020 --> Feb 2018 | Trial primary completion date: Feb 2018 --> Feb 2018
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD (clinicaltrials.gov) - Feb 23, 2018
P4, N=15, Completed, Sponsor: Massachusetts General Hospital
Recruiting --> Completed | Trial completion date: Oct 2020 --> Feb 2018 | Trial primary completion date: Feb 2018 --> Feb 2018 Recruiting --> Completed | N=40 --> 15 | Trial primary completion date: May 2018 --> Jan 2018 | Trial completion date: Nov 2018 --> Jan 2018